Human TCR Tetramer-PE (HLA-A*24:02 PBF145-153-AYRPVSRNI)
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
| Target | PBF145-153 |
|---|---|
| Product Type | Tetramer |
| Application | FCM |
| Conjugate | PE |
| Class | Others |
| Research Area | Immunology |
| Protocols | FCM |
| Host Species | Human |
| Immunogen | HLA-A*24:02 PBF145-153-AYRPVSRNI |
| Formulation | 0.5 mM EDTA, 0.2% BSA, 10 mM Tris-HCl (pH 8.0), 200 mM NaCl, and 0.09% NaN3. |
| Storage Temperature | Store at 2 to 8°C. Do not freeze. Minimize exposure to light. |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
Related Content
